RK
Therapeutic Areas
Arcadia Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GoodWheat™ | Reduced-carb, high-fiber, high-protein food ingredient | Commercial |
| HB4® Wheat (Water Use Efficiency) | Drought-tolerant wheat for sustainable farming | Regulatory & Pre-Commercial |
| High Fiber Wheat | Wheat with increased dietary fiber | Advanced Development |
| High Oleic Soybean | Soybean with improved oil stability and health profile | Commercial |
| Arcadia Specialty Hemp (Grain/Fiber) | Hemp for grain and fiber production | Commercial |
| Proprietary Hemp Genetics (CBD) | Hemp for cannabinoid (e.g., CBD) production | R&D / Early Commercial |
Leadership Team at Arcadia Biosciences
MT
Matthew T. Plavan
Chief Executive Officer
SJ
Stanley J. Jacot
Chief Financial Officer
SR
Sarah Reiter
Chief Business Officer
PH
Pamela Haley
Interim Chief Accounting Officer
JG
James G. Levine
Vice President, General Counsel & Corporate Secretary
KL
Kevin L. Comcowich
Chairman of the Board
RM
R. Michael Conley
Director
IP
Ivan P. Delevic
Director
WA
William A. Schmitz
Director